BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 34679258)

  • 21. The Effect of the SARS-CoV-2 Pandemic on Presentation with Diabetic Ketoacidosis in Children with New Onset Type 1 Diabetes Mellitus.
    Jalilova A; Ata A; Demir G; Işıklar H; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):264-267. PubMed ID: 36987789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DKA and new-onset type 1 diabetes in Brazilian children and adolescents during the COVID-19 pandemic.
    Luciano TM; Halah MP; Sarti MTA; Floriano VG; da Fonseca BAL; Del Roio Liberatore R; Antonini SR
    Arch Endocrinol Metab; 2022 Mar; 66(1):88-91. PubMed ID: 35029857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Initial Presentation of Pediatric Diabetes Before and During the Coronavirus Disease 2019 Pandemic Era.
    Lee Y; Kim M; Oh K; Kang E; Rhie YJ; Lee J; Hong YH; Shin YL; Kim JH
    J Korean Med Sci; 2022 Jun; 37(22):e176. PubMed ID: 35668686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of Children with Diabetic Ketoacidosis Treated in Pediatric Intensive Care Unit: Two-Center Cross-Sectional Study in Croatia.
    Burcul I; Arambasic N; Polic B; Kovacevic T; Bartulovic I; Catipovic Ardalic T; Markic J
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31295949
    [No Abstract]   [Full Text] [Related]  

  • 25. Increase in newly diagnosed type 1 diabetes in youth during the COVID-19 pandemic in the United States: A multi-center analysis.
    Wolf RM; Noor N; Izquierdo R; Jett D; Rewers A; Majidi S; Sheanon N; Breidbart E; Demeterco-Berggren C; Lee JM; Kamboj MK; Ebekozien O
    Pediatr Diabetes; 2022 Jun; 23(4):433-438. PubMed ID: 35218124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic Ketoacidosis and Long-term Insulin Requirements in Youths with Newly Diagnosed Type 2 Diabetes During the SARS-CoV-2 Pandemic.
    Hao S; Cossen K; Westbrook AL; Umpierrez GE; Vellanki P
    Endocr Pract; 2023 Oct; 29(10):754-761. PubMed ID: 37451650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of Type 1 Diabetes Mellitus and Characteristics of Diabetic Ketoacidosis in Children and Adolescents during the First Two Years of the COVID-19 Pandemic in Vojvodina.
    Vorgučin I; Savin M; Stanković Đ; Miljković D; Ilić T; Simić D; Vrebalov M; Milanović B; Barišić N; Stojanović V; Vijatov-Đurić G; Koprivšek K; Vilotijević-Dautović G; Antić J
    Medicina (Kaunas); 2022 Jul; 58(8):. PubMed ID: 36013479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketoacidosis at presentation of type 1 diabetes in children in Kuwait: frequency and clinical characteristics.
    Abdul-Rasoul M; Al-Mahdi M; Al-Qattan H; Al-Tarkait N; Alkhouly M; Al-Safi R; Al-Shawaf F; Mahmoud H
    Pediatr Diabetes; 2010 Aug; 11(5):351-6. PubMed ID: 19821943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of COVID-19 Pandemic Lockdown on the Incidence of New-Onset Type 1 Diabetes and Ketoacidosis Among Saudi Children.
    Alaqeel A; Aljuraibah F; Alsuhaibani M; Huneif M; Alsaheel A; Dubayee MA; Alsaedi A; Bakkar A; Alnahari A; Taha A; Alharbi K; Alanazi Y; Almadhi S; Khalifah RA
    Front Endocrinol (Lausanne); 2021; 12():669302. PubMed ID: 33868185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in Type 1 Diabetic Ketoacidosis During COVID-19 Surges at 7 US Centers: Highest Burden on non-Hispanic Black Patients.
    Lavik AR; Ebekozien O; Noor N; Alonso GT; Polsky S; Blackman SM; Chen J; Corathers SD; Demeterco-Berggren C; Gallagher MP; Greenfield M; Garrity A; Rompicherla S; Rapaport R; Yayah Jones NH
    J Clin Endocrinol Metab; 2022 Jun; 107(7):1948-1955. PubMed ID: 35380700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries.
    Birkebaek NH; Kamrath C; Grimsmann JM; Aakesson K; Cherubini V; Dovc K; de Beaufort C; Alonso GT; Gregory JW; White M; Skrivarhaug T; Sumnik Z; Jefferies C; Hörtenhuber T; Haynes A; De Bock M; Svensson J; Warner JT; Gani O; Gesuita R; Schiaffini R; Hanas R; Rewers A; Eckert AJ; Holl RW; Cinek O
    Lancet Diabetes Endocrinol; 2022 Nov; 10(11):786-794. PubMed ID: 36202118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of COVID-19 Pandemic on Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes: A Single-Centre Study in Central Pennsylvania.
    Bogale KT; Urban V; Schaefer E; Bangalore Krishna K
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00235. PubMed ID: 34268453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID-19 pandemic.
    Lawrence C; Seckold R; Smart C; King BR; Howley P; Feltrin R; Smith TA; Roy R; Lopez P
    Diabet Med; 2021 Jan; 38(1):e14417. PubMed ID: 33020999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketoacidosis at first presentation of type 1 diabetes mellitus among children: a study from Kuwait.
    Shaltout AA; Channanath AM; Thanaraj TA; Omar D; Abdulrasoul M; Zanaty N; Almahdi M; Alkandari H; AlAbdulrazzaq D; d'Mello L; Mandani F; Alanezi A; AlBasiry E; Alkhawari M
    Sci Rep; 2016 Jun; 6():27519. PubMed ID: 27328757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and factors associated with thyroid autoimmunity among children newly diagnosed with type 1 diabetes before and during the COVID-19 pandemic: Evidence from Kuwait.
    Al-Abdulrazzaq D; Albatineh AN; Khalifa D; Alrefae A; Al-Awadhi E; Alkandari A; Alhomaidah D; Cunningham SA; Al-Kandari H
    Diabetes Metab Res Rev; 2024 Jul; 40(5):e3824. PubMed ID: 38837532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uncovering the alarming rise of diabetic ketoacidosis during COVID-19 pandemic: a pioneer African study and review of literature.
    Gorchane A; Ach T; Sahli J; Abdelkrim AB; Mallouli M; Bellazreg F; Hachfi W; Chaieb MC; Ach K
    Front Endocrinol (Lausanne); 2023; 14():1234256. PubMed ID: 37564978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of COVID-19 pandemic on presentation and referral patterns of newly diagnosed children with type 1 diabetes in a developing country.
    Alassaf A; Gharaibeh L; Ibrahim S; Daher A; Irsheid A; Albaramki J; Odeh R
    J Pediatr Endocrinol Metab; 2022 Jul; 35(7):859-866. PubMed ID: 35607289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Diabetic Ketoacidosis in Childhood New-Onset Type 1 Diabetes With Day of Presentation in Germany.
    Kamrath C; Sindichakis M; Auzanneau M; Schmid S; Segerer H; Lahn V; Golembowsky S; Roessner-Cold D; Rauh K; Manuwald U; Holl RW
    Diabetes Care; 2024 Apr; 47(4):649-652. PubMed ID: 38128074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and outcome of hospitalized children and adolescent patients with type 1 diabetes during the COVID-19 pandemic: data from a single center surveillance study in Egypt.
    Sherif EM; Elhenawy YI; Matter RM; Aly HH; Thabet RA; Fereig YA
    J Pediatr Endocrinol Metab; 2021 Jul; 34(7):925-936. PubMed ID: 33882200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using population data to understand the epidemiology and risk factors for diabetic ketoacidosis in Australian children with type 1 diabetes.
    Ampt A; van Gemert T; Craig ME; Donaghue KC; Lain SB; Nassar N
    Pediatr Diabetes; 2019 Nov; 20(7):901-908. PubMed ID: 31291024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.